首页> 外文OA文献 >Is there any advantage from continuation of trastuzumab beyond progression in metastatic her positive gastric cancer? report of two cases and literature review

【2h】

Is there any advantage from continuation of trastuzumab beyond progression in metastatic her positive gastric cancer? report of two cases and literature review

机译：从血迹延续超出转移的阳性胃癌中的进展情况是否存在任何优势？报告两种病例与文献综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Rachid Tanz; Tarik Mahfoud; Ilyas El Alami; Aziz Bazine; Hassan Errihani; Mohamed Ichou;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience [J] . Humaid O. Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, Journal of Gastrointestinal Oncology . 2016,第4期

机译：曲妥珠单抗超越HER2阳性转移性胃癌疾病进展的延续：MD Anderson的经验
2. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience [J] . Humaid O. Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, Journal of Gastrointestinal Oncology . 2016,第4期

机译：曲妥珠单抗超越HER2阳性转移性胃癌疾病进展的延续：MD Anderson的经验
3. Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature [J] . Arcienega Isabel Ihnenfeld, Imesch Patrick, Fink Daniel, Targeted oncology . 2015,第2期

机译：连续曲妥珠单抗治疗后转移性HER2阳性乳腺癌的长期完全缓解：一例病例并文献复习
4. Combination of Novel HER2 Targeting Antibody 1A12 with Trastuzumab Shows Synergistic Antitumor Activity in HER2 Positive Gastric Cancer [C] . Kyu-Tae Kim, Jong-Seo Lee, Ki-Hyun Kim, PEGS . 2015

机译：具有曲妥珠单抗的新型HER2靶向抗体1a12的组合在HER2阳性胃癌中显示了协同抗肿瘤活性
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Continuation of trastuzumab beyond disease progression in HER2-positive metastatic gastric cancer: the MD Anderson experience [O] . Humaid O. Al-Shamsi, Yazan Fahmawi, Ibrahim Dahbour, 2016

机译：曲妥珠单抗在HER2阳性转移性胃癌疾病进展中的延续：MD Anderson的经验
7. Prolonged complete remission of metastatic HER2-positive breast cancer after continuous trastuzumab treatment: a case report and review of the literature [O] . Ihnenfeld Arciénega, Isabel, Imesch, Patrick, Fink, Daniel, 2015

机译：连续曲妥珠单抗治疗后转移性HER2阳性乳腺癌的长期完全缓解：一例病例并文献复习

Is there any advantage from continuation of trastuzumab beyond progression in metastatic her positive gastric cancer? report of two cases and literature review

著录项

相似文献

相关主题

期刊订阅